London, Canada

Gyoung Nyoun Kim

This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Other. Active years: 2016-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gyoung Nyoun Kim. Retrieved from https://idiyas.com/inventor/gyoung-nyoun-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • London, GB (2017)
  • London, CA (2016 - 2018)

Company Filing History:

goldMedal6 out of 834,601 
Other
 patents

Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gyoung Nyoun Kim

Introduction

Gyoung Nyoun Kim, an accomplished inventor based in London, CA, has made significant strides in the field of virology through his innovative work on recombinant vesicular stomatitis virus (rVSV) vaccines. With a total of six patents to his name, Kim's cutting-edge research and inventions demonstrate a deep understanding of viral matrix proteins and their potential applications in immunology.

Latest Patents

Among his latest patents, Gyoung Nyoun Kim has developed modified matrix proteins of vesicular stomatitis virus (VSV). One notable invention involves mutant M proteins, which include specific amino acid changes aimed at enhancing the virus's properties. For example, one variant features a glycine to glutamic acid change at position 21, a leucine changed to alanine at position 111, and a methionine altered to an arginine at position 51. These modifications lead to rVSVs that are significantly attenuated, exhibiting a loss of virulence, including neurovirulence, while still capable of inducing immune responses against specific antigens. Another patent focuses on recombinant VSVs that replicate efficiently at 31°C but poorly at higher temperatures, showcasing the potential for tailored vaccine strategies.

Career Highlights

Throughout his career, Gyoung Nyoun Kim has been associated with reputable institutions, such as The University of Western Ontario, where he contributed to advancing the understanding of viral mechanisms and vaccine development. His research has paved the way for innovation in the field of immunotherapy and the creation of effective vaccine vectors.

Collaborations

Kim has collaborated with esteemed colleagues, including Chil-Yong Kang, fostering an environment of shared knowledge and expertise. These partnerships have played a crucial role in the advancement of his inventions, further solidifying his impact on the scientific community.

Conclusion

Gyoung Nyoun Kim's contributions to the field of virology through his innovative patents on modified matrix proteins of vesicular stomatitis virus reflect both his expertise and dedication as an inventor. His work not only enhances our understanding of viral behavior but also opens new avenues for vaccine development, marking him as a key figure in contemporary scientific innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…